Spots Global Cancer Trial Database for cis
Every month we try and update this database with for cis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma | NCT03267940 | Cholangiocarcin... Cholangiocarcin... Cholangiocarcin... Gallbladder Ade... | PEGPH20 CIS GEM Atezolizumab | 18 Years - | Halozyme Therapeutics | |
| Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. | NCT03335059 | Bladder Cancer Bladder Neoplas... Bladder Tumors Cancer of Bladd... Cancer of the B... Malignant Tumor... Neoplasms, Blad... Urinary Bladder... Carcinoma in Si... Papillary Carci... BCG-Unresponsiv... | Synergo® RITE +... | 18 Years - | Medical Enterprises Ltd. | |
| Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG) | NCT01316874 | Carcinoma in Si... Bladder Cancer | Valrubicin, 800... | 18 Years - | Endo Pharmaceuticals | |
| Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma | NCT03267940 | Cholangiocarcin... Cholangiocarcin... Cholangiocarcin... Gallbladder Ade... | PEGPH20 CIS GEM Atezolizumab | 18 Years - | Halozyme Therapeutics | |
| Pneumoperitoneum Management With Low vs. Higher Pressure | NCT03128281 | Malignant Neopl... | Questionnaires Conventional In... ConMed AirSeal ... ConMed AirSeal ... | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| Pneumoperitoneum Management With Low vs. Higher Pressure | NCT03128281 | Malignant Neopl... | Questionnaires Conventional In... ConMed AirSeal ... ConMed AirSeal ... | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| Retrospective Chart Review of Valstar | NCT01304173 | Carcinoma in Si... | 18 Years - | Endo Pharmaceuticals | ||
| A Prospective Study Examining the Barriers to Care for Harris County Cervical Cancer Patients | NCT00519272 | Cervical Cancer | Questionnaire | - | M.D. Anderson Cancer Center | |
| Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. | NCT03335059 | Bladder Cancer Bladder Neoplas... Bladder Tumors Cancer of Bladd... Cancer of the B... Malignant Tumor... Neoplasms, Blad... Urinary Bladder... Carcinoma in Si... Papillary Carci... BCG-Unresponsiv... | Synergo® RITE +... | 18 Years - | Medical Enterprises Ltd. | |
| Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus | NCT01236443 | Barrett's Esoph... CIS High Grade Dysp... | HPPH | 18 Years - | Roswell Park Cancer Institute | |
| A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC) | NCT01314664 | Bladder Cancer CIS | 18 Years - | Endo Pharmaceuticals |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
